Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice

Background: Mesenchymal stromal cells (MSCs) are an attractive cell type for cell therapy given their immunomodulatory, anti-fibrotic, and endothelial-protective features. The heparin sulfate proteoglycan, syndecan-2/CD362, has been identified as a functional marker for MSC isolation, allowing one t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pappritz, Kathleen, Dong, Fengquan, Miteva, Kapka, Kovacs, Arpad, El-Shafeey, Muhammad, Kerim, Bahtiyar, O'Flynn, Lisa, Elliman, Stephen Joseph, O'Brien, Timothy, Hamdani, Nazha, Tschöpe, Carsten, Van Linthout, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175674/
https://www.ncbi.nlm.nih.gov/pubmed/34095245
http://dx.doi.org/10.3389/fcvm.2021.632728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175674/
https://www.ncbi.nlm.nih.gov/pubmed/34095245
http://dx.doi.org/10.3389/fcvm.2021.632728

Ejemplares similares